{
    "title": "AstraZeneca's rare disease arm in $1 bln deal for Pfizer gene therapies",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12347733/AstraZeneca-buy-Pfizers-rare-disease-gene-therapy-portfolio-1-bln.html",
    "date": "2023-07-28",
    "keywords": [
        "alexion",
        "gene",
        "therapy",
        "astrazeneca",
        "deal",
        "yadarisa",
        "drugmaker",
        "company",
        "head",
        "research",
        "vaccine",
        "quarter",
        "aav",
        "developer",
        "friday",
        "unit",
        "disease",
        "portfolio",
        "sharon",
        "barr",
        "development",
        "mene",
        "pangalos",
        "face",
        "companys",
        "covid",
        "pfizer",
        "number",
        "virus",
        "help",
        "astrazenecas",
        "medicine",
        "mechanism",
        "october",
        "logicbio",
        "merck",
        "amp",
        "co",
        "abbvie",
        "april",
        "drop",
        "valuation",
        "january",
        "drug",
        "cincor",
        "pharma",
        "stock",
        "heart",
        "kidney",
        "performance",
        "blockbuster",
        "cancer",
        "loss",
        "reporting",
        "shabong",
        "bengaluru",
        "editing",
        "bhattacharjee",
        "mark",
        "potter"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}